MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/lifemedi/lnag017

Медицинская библиотека · Life medicine · 2026

TRIM22-mediated ubiquitin-dependent degradation of FLT3-ITD overcomes TKI resistance in acute myeloid leukemia.

Liu Meng, Wang Xiaoqian, He Xiaqin, Xu Xiaoguang, Chen Jing, Liu Juan, Jiang Shan, Li Sijia, Wang Si, Liu Yuanyuan, Feng Jing, Xu Xin, Luo Miaoyin, Li Zhiyi, Zhang Yining, Wu Yingli, Hu Jian, Wang Xiaoqin

СтатьяПеревод в очереди

Аннотация

FMS-like tyrosine kinase 3 internal tandem duplication (FLT3-ITD) mutations, found in 25%-30% of acute myeloid leukemia (AML) patients, cause poor prognosis and resistance to FLT3 tyrosine kinase inhibitors (TKIs). We show that APG-115 selectively kills FLT3-ITD cells by activating p53. This critically upregulates TRIM22 (Tripartite motif-containing protein 22), an essential E3 ubiquitin ligase that directly binds FLT3-ITD, promotes its polyubiquitination, and induces its proteasomal degradation. This TRIM22-mediated mechanism offers a novel strategy to overcome intrinsic and acquired TKI resistance. Unlike inhibitors such as AC220, which suppress FLT3 signaling but downregulate p53, APG-115 restores p53 function and induces TRIM22, enabling potent synergy with FLT3 inhibitors. TRIM22 is essential for APG-115's suppression of leukemia stem cells, inducing cell cycle arrest, myeloid differentiation, and reduced clonogenic potential. The combination of APG-115 and AC220 significantly enhances apoptosis in FLT3-ITD AML models and primary cells, while sparing normal cells. It shows robust efficacy in preclinical xenograft models, reducing tumor burden and extending survival. This work establishes targeting the p53/TRIM22 axis, reliant on TRIM22's unique activity against FLT3-ITD, as a highly promising therapeutic approach for FLT3-ITD AML, including resistant disease.

Для цитирования: Liu Meng, Wang Xiaoqian, He Xiaqin, Xu Xiaoguang, Chen Jing, Liu Juan, Jiang Shan, Li Sijia, Wang Si, Liu Yuanyuan, Feng Jing, Xu Xin, Luo Miaoyin, Li Zhiyi, Zhang Yining, Wu Yingli, Hu Jian, Wang Xiaoqin. TRIM22-mediated ubiquitin-dependent degradation of FLT3-ITD overcomes TKI resistance in acute myeloid leukemia.. Life medicine. 2026. DOI: 10.1093/lifemedi/lnag017.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.